Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and Other Liabilities (Details)

v3.21.1
Accrued expenses and Other Liabilities (Details) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Accrued expenses and Other Liabilities    
Accrued clinical trial expenses $ 1,086,202 $ 628,000
Accrued manufacturing expenses 15,000 175,089
Compensation and related benefits 225,095 209,600
Accrued franchise tax 55,000 172,500
Other expenses 383,088 429,345
Accrued expenses $ 1,764,385 $ 1,614,534